Management at newly listed GE HealthCare is arguing that a more nimble company will make faster and better decisions.Photo: Bloomberg

Healthcare spinoffs are everywhere you look these days. 

Just in the first week of January, Johnson & Johnson‘s consumer unit Kenvue officially filed for an initial public offering, GE‘s newly spun-off healthcare unit started trading and Baxter announced plans to spin off its kidney care unit. Swiss giant Novartis, meanwhile, is working on spinning off its generic Sandoz business.

Continue reading your article with

a WSJ membership

View Membership Options

Already a member? Sign In


Please enter your comment!
Please enter your name here